<?xml version="1.0" encoding="UTF-8" ?><dbgapss xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:noNamespaceSchemaLocation="dbgapssws.1.0.xsd"><Study uid="16970" whole_study_id="16970" phs="001136" v="1" p="1" createDate="2015-09-24T15:07:51-05:00" completedByGPADate="2015-10-29T13:57:23-05:00" modDate="2022-01-25T16:16:12-05:00" maxParentChildStudyModDate="2022-01-25T16:16:12-05:00" handle="FamilialDyslipidemia_Finnish" num_participants=""><StudyInfo accession="phs001136.v1.p1" parentAccession="phs001136.v1.p1"><BioProject id="PRJNA324461" entrez_id="324461" type="bp_admin_access"/><BioProject id="PRJNA324462" entrez_id="324462" type="bp_data_submission"/><StudyNameEntrez>Genomic And Metabolomic Profiling Of Finnish Familial Dyslipidemia Families</StudyNameEntrez><StudyTypes2 calculated="Yes"><StudyType21 name="phenotype_data" chosen="Yes"/><StudyType21 name="analysis" chosen="No"/><StudyType21 name="individual_sequencing" chosen="Yes"><StudyType22 name="ncbi_for_sequence"/><StudyType22 name="whole_targ_genome"/></StudyType21><StudyType21 name="supporting_documents" chosen="No"/><StudyType21 name="images" chosen="No"/><StudyType21 name="molecular" chosen="No"/><StudyType21 name="subject_samples" chosen="Yes"/><StudyType21 name="links_to_ncbi_dbs" chosen="No"/><StudyType21 name="other_general" chosen="No"/></StudyTypes2><StudyTypes><StudyType>phenotype_data</StudyType><StudyType>individual_sequencing</StudyType><StudyType>whole_genome</StudyType><StudyType>sra</StudyType></StudyTypes><SraStorages/><Funding>R01 HL113315</Funding></StudyInfo><Authority><ICs><IC id="12" name="NHLBI" is_funding_ic="true" is_admin_ic="true" primary="true"/></ICs><Persons><Person nedid="FREIMER2" aid="2" auth="eRA" login="FREIMER2" fname="Nelson" mname="B" lname="Freimer" email="nfreimer@mednet.ucla.edu"><Role>PI</Role><Organization>UNIVERSITY OF CALIFORNIA LOS ANGELES</Organization></Person><Person nedid="0010055357" aid="1" auth="cit" login="jaquishc" fname="Cashell" mname="E" lname="Jaquish" email="cj68r@nih.gov"><Role>PO</Role><Organization>NIH</Organization></Person><Person aid="8" auth="virtual" fname="Terri" lname="Teshiba" email="tteshiba@mednet.ucla.edu"><Role>PI_ASSIST</Role><Organization/></Person><Person nedid="0012988688" aid="1" auth="cit" login="popovan" fname="Natalia" mname="V" lname="Popova" email="popovan@ncbi.nlm.nih.gov"><Role>PHENO_CURATOR</Role><Organization>NIH</Organization></Person><Person nedid="0011559580" aid="1" auth="cit" login="stefanov" fname="Stefan" mname="Alexandrov" lname="Stefanov" email="stefanov@mail.nih.gov"><Role>GENO_CURATOR</Role><Organization>NIH</Organization></Person><Person nedid="2001545300" aid="1" auth="cit" login="lic17" fname="Chengyuan" mname="" lname="Press" email="chanel.press@nih.gov"><Role>GPA</Role><Organization>NIH</Organization></Person></Persons></Authority><Policy display-research-statement="true" display-public-summary="true" years-until-renewal="1" weeks-to-cancel-request="8" pub-embargo="none"><acknowledgement_statement>The EUFAM study has been funded mainly by the European Commission (contract BMH4-CT96-1678). Additional funding has been obtained from the Academy of Finland, the Finnish Heart Foundation and the Helsinki University Central Hospital Research Foundation. We would like to thank the participants of the EUFAM study for making this work possible. The study has been described in Porkka KV et al (1997) and Pajukanta P et al (1999).

Porkka KV, Nuotio I, Pajukanta P, Ehnholm C, Suurinkeroinen L, Syv&#228;nne M, Lehtim&#228;ki T, Lahdenkari AT, Lahdenper&#228; S, Ylitalo K, Antikainen M, Perola M, Raitakari OT, Kovanen P, Viikari JS, Peltonen L, Taskinen MR.  Atherosclerosis. 1997 Sep;133(2):245-53.

Pajukanta P, Terwilliger JD, Perola M, Hiekkalinna T, Nuotio I, Ellonen P, Parkkonen M, Hartiala J, Ylitalo K, Pihlajam&#228;ki J, Porkka K, Laakso M, Viikari J, Ehnholm C, Taskinen MR, Peltonen L. Genomewide scan for familial combined hyperlipidemia genes in finnish families, suggesting multiple susceptibility loci influencing triglyceride, cholesterol, and apolipoprotein B levels. Am J Hum Genet. 1999 May;64(5):1453-63.
</acknowledgement_statement><ic_specific_access_term>There is one consent group for this study: DS-LMC-IRB, Disease-Specific (Lipid Metabolism Control, IRB).
Use of the data must be related to Lipid Metabolism Control.
Requestor must provide documentation of local IRB approval.
Use of the data is limited only by the terms of the model Data Use Certification.</ic_specific_access_term><DUC universal_duc="Yes"><File full_url="https://dbgap.ncbi.nlm.nih.gov/aa/docs/Static_DUC_20190419.pdf" filename="Static_DUC_20190419.pdf" content-type="application/pdf"/></DUC><DUC_PDF universal_duc="Yes"><File full_url="https://dbgap.ncbi.nlm.nih.gov/aa/docs/Static_DUC_20190419.pdf" filename="Static_DUC_20190419.pdf" content-type="application/pdf"/></DUC_PDF><GSR_Access gsr_mode="unrest_access_old_cert" gsr_mode_label="Unrestricted access (institution responded that the study is not sensitive without submitting a new Institutional Certification)"/><ConsentGroup uid="1782" CGType="cg_class_DS" title="Disease-Specific (Lipid Metabolism Control, IRB)" name="DS-LMC-IRB" dac_uid="56" dac_name="NHLBI" irb-approval-required="Yes"><Use-Restriction>Use of the data must be related to Lipid Metabolism Control.
Requestor must provide documentation of local IRB approval.

</Use-Restriction></ConsentGroup><ConsentGroup uid="1851" CGType="cg_class_other" title="Exchange Area use by Finnish Familial Dyslipedemia study investigators only" name="EA-IRB" dac_uid="56" dac_name="NHLBI" irb-approval-required="Yes"><Use-Restriction>There is one consent group for this study: DS-LMC-IRB, Disease-Specific (Lipid Metabolism Control, IRB).
Use of the data must be related to Lipid Metabolism Control.
Requestor must provide documentation of local IRB approval.</Use-Restriction></ConsentGroup></Policy><SRA/><Documents/><Status uid="14" name="completed_by_gpa" title="Completed by GPA"/></Study></dbgapss>